| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Okt―25 |
Assessing the Impact of the COVID-19 Pandemic on the Severity of Pediatric Inflammatory Bowel Disease Admissions and New Diagnoses |
Malika Waschmann, Ariana Stuart, Kimberly Trieschmann, Henry C Lin, Anna K Hunter |
| 2 |
[GO] |
2023―Sep―06 |
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study |
Aakash Desai, Jana G Hashash, Gursimran S Kochhar, Francis A Farraye |
| 3 |
[GO] |
2022―Mrz―28 |
Risks of Development of COVID-19 among Patients with Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection |
Millie D Long, Xian Zhang, James D Lewis, Gil Y Melmed, Corey A Siegel, Emily Cerciello, et al. (+4) Angela Dobes, Alandra Weaver, Laura Weisbein, Michael D Kappelman |
| 4 |
[GO] |
2020―Apr―14 |
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients |
Peter D R Higgins, Siew Ng, Silvio Danese, Krishna Rao |
|
